SugarDaddy1
Literotica Guru
- Joined
- Dec 6, 2012
- Posts
- 1,901
Anti-abortion advocates are confident that the Supreme Court’s decision to review the Food and Drug Administration’s approval of the abortion drug mifepristone will permanently restrict access to the controversial medication.
In August, the U.S. Court of Appeals for the 5th Circuit partially upheld the decision of Texas District Judge Matthew Kacsmaryk to block the FDA’s approval of mifepristone, prompting drugmaker Danco Laboratories to seek emergency relief from the Supreme Court in early September.
The Charlotte Lozier Institute conducted a study of the 17 state Medicaid programs that cover elective abortions and found that 1 in 20 women visited an emergency room within one month of a chemical abortion. Other studies have found that between 15% and 35% of women prescribed mifepristone do not return to their physicians for follow-up care, leaving the true complication rate unknown.
“I think when you look at the science, you recognize that the way chemical abortions are being allowed to be used without any medical supervision is very dangerous for women,” Skop said.
https://www.washingtonexaminer.com/...tion-advocates-supreme-court-fight-mail-pills